DK1817326T3 - Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde - Google Patents
Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmådeInfo
- Publication number
- DK1817326T3 DK1817326T3 DK05797354.7T DK05797354T DK1817326T3 DK 1817326 T3 DK1817326 T3 DK 1817326T3 DK 05797354 T DK05797354 T DK 05797354T DK 1817326 T3 DK1817326 T3 DK 1817326T3
- Authority
- DK
- Denmark
- Prior art keywords
- beta
- bismethylene
- pregn
- lactone
- ene
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- Lubricants (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0402465A HUP0402465A2 (en) | 2004-11-30 | 2004-11-30 | Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process |
| PCT/HU2005/000110 WO2006059167A1 (en) | 2004-11-30 | 2005-10-11 | INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,16β-BISMETHYLENE-3-OXO-17α-PREGN-4-ENE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1817326T3 true DK1817326T3 (da) | 2010-08-30 |
Family
ID=89985651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05797354.7T DK1817326T3 (da) | 2004-11-30 | 2005-10-11 | Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8309712B2 (da) |
| EP (1) | EP1817326B1 (da) |
| JP (1) | JP4971179B2 (da) |
| CN (1) | CN101061133B (da) |
| AT (1) | ATE468349T1 (da) |
| AU (1) | AU2005311059B2 (da) |
| CA (1) | CA2585802C (da) |
| CY (1) | CY1110098T1 (da) |
| DE (1) | DE602005021395D1 (da) |
| DK (1) | DK1817326T3 (da) |
| ES (1) | ES2345560T3 (da) |
| HK (1) | HK1107354A1 (da) |
| HU (1) | HUP0402465A2 (da) |
| PL (1) | PL1817326T3 (da) |
| PT (1) | PT1817326E (da) |
| SI (1) | SI1817326T1 (da) |
| WO (1) | WO2006059167A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20042338A1 (it) * | 2004-12-06 | 2005-03-06 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| EP2019114B1 (en) * | 2007-07-26 | 2010-12-15 | Newchem S.p.A. | Process for the preparation of Drospirenone |
| US7960368B2 (en) * | 2008-03-05 | 2011-06-14 | Everstra, Inc. | Bismethylene-17A carbolactones and related uses |
| US8222237B2 (en) * | 2008-11-25 | 2012-07-17 | Evestra, Inc. | Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones |
| US8334375B2 (en) * | 2009-04-10 | 2012-12-18 | Evestra, Inc. | Methods for the preparation of drospirenone |
| DE102009031907B4 (de) * | 2009-07-01 | 2017-02-09 | Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Verfahren zur Herstellung von Drospirenon aus Androstendion |
| DE102009031909B4 (de) * | 2009-07-01 | 2017-02-09 | Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Verfahren zur Herstellung von Drospirenon aus Prasteron |
| DE102009038972A1 (de) * | 2009-08-23 | 2011-06-30 | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, 14167 | Verfahren zur Herstellung von Drospirenon aus 6,7,15,16-Dimethylenandrost-4-en-3,17-dion |
| DE102009031908B4 (de) * | 2009-07-01 | 2017-02-09 | Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg | Verfahren zur Herstellung von Drospirenon aus 15-Hydroxyandrostendion |
| CN109232700B (zh) * | 2018-09-17 | 2020-06-26 | 宁波三生生物科技有限公司 | 一种烯丙孕素的高效合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH540896A (de) * | 1966-04-02 | 1973-10-15 | Schering Ag | Verfahren zur Herstellung von 15,16B-Methylensteroiden |
| CH505080A (de) * | 1968-04-22 | 1971-03-31 | Hoffmann La Roche | Verfahren zur Herstellung neuer Pregnene |
| DE2652761C2 (de) * | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE2746298A1 (de) * | 1977-10-13 | 1979-04-19 | Schering Ag | 4-androsten-3,17-dion-derivate, ihre herstellung und verwendung |
| DE3042136A1 (de) * | 1980-11-03 | 1982-06-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden |
| EP0075189B1 (en) * | 1981-09-21 | 1985-08-28 | Schering Aktiengesellschaft | 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation |
| DE19633685C1 (de) * | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
-
2004
- 2004-11-30 HU HU0402465A patent/HUP0402465A2/hu unknown
-
2005
- 2005-10-11 PT PT05797354T patent/PT1817326E/pt unknown
- 2005-10-11 DE DE602005021395T patent/DE602005021395D1/de active Active
- 2005-10-11 CA CA002585802A patent/CA2585802C/en active Active
- 2005-10-11 AU AU2005311059A patent/AU2005311059B2/en active Active
- 2005-10-11 CN CN2005800398624A patent/CN101061133B/zh active Active
- 2005-10-11 SI SI200531046T patent/SI1817326T1/sl unknown
- 2005-10-11 AT AT05797354T patent/ATE468349T1/de active
- 2005-10-11 DK DK05797354.7T patent/DK1817326T3/da active
- 2005-10-11 US US11/719,333 patent/US8309712B2/en active Active
- 2005-10-11 ES ES05797354T patent/ES2345560T3/es active Active
- 2005-10-11 JP JP2007543936A patent/JP4971179B2/ja active Active
- 2005-10-11 EP EP05797354A patent/EP1817326B1/en active Active
- 2005-10-11 PL PL05797354T patent/PL1817326T3/pl unknown
- 2005-10-11 WO PCT/HU2005/000110 patent/WO2006059167A1/en active Application Filing
-
2008
- 2008-02-01 HK HK08101261.2A patent/HK1107354A1/xx unknown
-
2010
- 2010-06-17 CY CY20101100558T patent/CY1110098T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU0402465D0 (en) | 2005-01-28 |
| JP4971179B2 (ja) | 2012-07-11 |
| HUP0402465A2 (en) | 2006-07-28 |
| CN101061133B (zh) | 2011-01-26 |
| PL1817326T3 (pl) | 2010-10-29 |
| US20080200668A1 (en) | 2008-08-21 |
| PT1817326E (pt) | 2010-06-25 |
| EP1817326B1 (en) | 2010-05-19 |
| ATE468349T1 (de) | 2010-06-15 |
| CY1110098T1 (el) | 2015-01-14 |
| EP1817326A1 (en) | 2007-08-15 |
| DE602005021395D1 (de) | 2010-07-01 |
| ES2345560T3 (es) | 2010-09-27 |
| AU2005311059B2 (en) | 2011-01-06 |
| US8309712B2 (en) | 2012-11-13 |
| CA2585802C (en) | 2009-09-08 |
| SI1817326T1 (sl) | 2010-08-31 |
| JP2008521875A (ja) | 2008-06-26 |
| CA2585802A1 (en) | 2006-06-08 |
| AU2005311059A1 (en) | 2006-06-08 |
| HK1107354A1 (en) | 2008-04-03 |
| CN101061133A (zh) | 2007-10-24 |
| WO2006059167A1 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1817326T3 (da) | Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde | |
| DK1831239T3 (da) | Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde | |
| TNSN07196A1 (en) | Potentiators of glutamate receptors | |
| MX339476B (es) | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. | |
| DE602004006618D1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
| HRP20070043A2 (en) | Antiviral compounds | |
| UA117800C2 (uk) | Похідні урацилу або тиміну для лікування гепатиту с | |
| EA201100311A1 (ru) | Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
| ATE412649T1 (de) | Substituierte heteroarylbenzofuransäuren | |
| DK1456212T3 (da) | 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse | |
| CR8111A (es) | Derivados sustituidos del pirrol | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| DK1926732T3 (da) | Fremgangsmåde til fremstillingen af carbapenemforbindelser | |
| NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
| DK1487859T3 (da) | Fremstillingsmetoder til at fremstille Eplerenon | |
| DK1441724T3 (da) | Fremgangsmåde til forögelse af endogene testosteronniveauer | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| CY1112501T1 (el) | Φαρμακευτικες συνθεσεις περιεχουσες λεφλουνομιδη | |
| DK1893597T3 (da) | AMPA-receptorpotentiatorer | |
| ATE377020T1 (de) | Kristallines gamma-lacton der17beta-hydroxy- | |
| DK1737855T3 (da) | Fremgangsmåde til halvsyntese af deserpidin | |
| DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
| NO20053829D0 (no) | Fremgangsmate og intermediater for fremstilling av olanzapin. |